Verify payer-specific coding requirements. For reimbursement information, please contact Sandoz One Source.

Learn about ZIEXTENZO (pegfilgrastim-bmez), the long-acting G-CSF treatment option from Sandoz2
G-CSF=granulocyte colony-stimulating factor.
References: 1. ZARXIO Prescribing Information. Sandoz Inc. September 2022. 2. ZIEXTENZO Prescribing Information. Sandoz Inc. March 2021.